Replies to post #247612 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Many companies worked with Chardan, and you don’t have a lot of choice at this level of market development.

As for management being to blame for being shorted by a social media short and distort campaign that targeted a virtually ubiquitous MFN clause, though they were more vulnerable than many, that targeting tactic is not widely understood and seems not to apply for companies that do not have long regulatory waiting periods to get a product to market or to private equity companies. Rather, it seems that most large, experienced law firms and top lawyers are repeatedly failing companies that trust them to negotiate these contracts and protect them. On the other hand, it is hard to predict that people as evil as those who trade for hedge funds even exist let alone will target companies trying to address such suffering. Most people do not anticipate such POS’s exist.

[JerryCampbell]

The two top execs at nwbo are lawyers.

They're not doing the MD and PhD work on the clinical side.

They're supposed to be good at things like reading NASDAQ legalese and judging people with whom they deal. No free pass for failure on those tasks.